Medtronic plc (MDT)

NYSE: MDT · Real-Time Price · USD
98.57
-1.30 (-1.30%)
At close: Dec 15, 2025, 4:00 PM EST
98.34
-0.23 (-0.23%)
Pre-market: Dec 16, 2025, 8:01 AM EST
-1.30%
Market Cap126.37B
Revenue (ttm)34.76B
Net Income (ttm)4.76B
Shares Out 1.28B
EPS (ttm)3.69
PE Ratio26.71
Forward PE16.81
Dividend$2.84 (2.88%)
Ex-Dividend DateDec 26, 2025
Volume9,569,280
Open99.90
Previous Close99.87
Day's Range98.35 - 100.67
52-Week Range79.29 - 106.33
Beta0.72
AnalystsBuy
Price Target108.63 (+10.21%)
Earnings DateNov 18, 2025

About MDT

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair produc... [Read more]

Sector Healthcare
Founded 1949
Employees 95,000
Stock Exchange NYSE
Ticker Symbol MDT
Full Company Profile

Financial Performance

In 2025, Medtronic's revenue was $33.54 billion, an increase of 3.62% compared to the previous year's $32.36 billion. Earnings were $4.66 billion, an increase of 26.82%.

Financial Statements

Analyst Summary

According to 18 analysts, the average rating for MDT stock is "Buy." The 12-month stock price target is $108.63, which is an increase of 10.21% from the latest price.

Price Target
$108.63
(10.21% upside)
Analyst Consensus: Buy
Stock Forecasts

News

Dividend Income: Lanny's October 2025 Summary

In October, we (my wife and I) received a dividend income total of $3,948.78. Crushing it for an off-month – thanks to Vanguard (VOO) and Fidelity (FXAIX) for paying in October. We had quite a few div...

Other symbols: BNLBNSBRTCAHCMCSCODEO
1 day ago - Seeking Alpha

This Dividend Stock Just Hit a Major Milestone. Time to Buy?

Medtronic earned regulatory clearance in the U.S. for its Hugo robotic-assisted surgery system. This device will take time to have a material impact on the company's financial results.

1 day ago - The Motley Fool

3 Dividend Stocks to Hold for the Next 10 Years

United Parcel Service is undergoing a business overhaul. General Mills appears to be an opportunity for value investors.

Other symbols: GISUPS
1 day ago - The Motley Fool

Medtronic: This Dividend Aristocrat Is Just Getting Started

Medtronic is regaining momentum, driven by double-digit growth in key cardiac franchises and a raised full-year revenue outlook. MDT's pulsed-field ablation business surged, with U.S. PFA sales more t...

6 days ago - Seeking Alpha

Medtronic announces cash dividend for third quarter of fiscal year 2026

GALWAY, Ireland , Dec. 4, 2025 /PRNewswire/ -- The board of directors of Medtronic plc (NYSE: MDT) on Thursday, December 4, 2025, approved the company's cash dividend for the third quarter of fiscal y...

11 days ago - PRNewsWire

Prediction: 1 Healthcare Giant Set to Soar in 2026

Medtronic recently delivered strong quarterly results thanks to a fast-growing franchise. This tailwind, along with others, could help maintain the stock's momentum into 2026.

12 days ago - The Motley Fool

Medtronic announces FDA clearance of Hugo™ robotic-assisted surgery system for urologic surgical procedures

Hugo RAS system brings choice to the U.S., coupled with the full suite of Medtronic surgical offerings, ultimately creating a connected and integrated operating room today and into the future. GALWAY,...

12 days ago - PRNewsWire

Medtronic begins U.S. commercial launch of the MiniMed™ 780G system with the Instinct sensor, made by Abbott

GALWAY, Ireland , Dec. 2, 2025  /PRNewswire/ -- Medtronic (NYSE: MDT), a global leader in healthcare technology, today announced the broad U.S. commercial launch of the MiniMed™ 780G system integrated...

13 days ago - PRNewsWire

3 Stocks to Buy and Hold: the Long-Term Play for Your Portfolio

Intuitive Surgical shows why now is a good time to consider buying surgical-robot competitor Medtronic. Eli Lilly helps explain why down-and-out drugmaker Pfizer could be worth a close look for long-t...

Other symbols: JNJPFE
16 days ago - The Motley Fool

Best Dividend Aristocrats For December 2025

The ProShares S&P 500 Dividend Aristocrats ETF (NOBL) has underperformed the SPDR S&P 500 ETF (SPY) year-to-date, but November shows a reversal. Several Dividend Aristocrats, including CAH, CAT, CHRW,...

17 days ago - Seeking Alpha

Robotics can 'democratize good healthcare' worldwide: Medtronic CEO

Medtronic Chairman and CEO Geoffrey Martha discusses the company's latest robotic innovation and how robotics can impact healthcare on 'The Claman Countdown.' #fox #media #us #usa #new #news #foxbusin...

18 days ago - Fox Business

5 Top Dividend Stocks to Buy in November

For investors, it's generally wise to buy and hold companies that continually raise their dividends. There are deals in energy, healthcare, consumer staples, and even the tech space.

Other symbols: ADPCLCLXCVX
21 days ago - The Motley Fool

This Medtech Giant's Stock Is Soaring. Should You Buy It Ahead of 2026?

Medtronic not only performed better than expected in its most recent quarter, but also raised its guidance. The company's innovation is paying off, and will do so again as it launches new products.

22 days ago - The Motley Fool

Which 'Dividend Prince' Will Become The Next King In 2 Years?

Medtronic has increased its dividend payment for 48 consecutive years. The global healthcare technology company has a very healthy dividend.

22 days ago - The Motley Fool

What Are the Best Healthcare Stocks to Buy Now? I Think It's Intuitive Surgical (ISRG) -- or, to Play It Safer, Medtronic (MDT)

Intuitive Surgical is the 800-pound gorilla in the robotic surgery space. Medtronic is entering the field and pays a solid dividend, too.

Other symbols: ISRG
22 days ago - The Motley Fool

2 Fantastic Dividend Stocks to Buy and Hold Forever

Abbott and Medtronic are innovative healthcare leaders that generate consistent revenue and profits. They also have attractive long-term prospects and have consistently raised their dividend payouts.

Other symbols: ABT
25 days ago - The Motley Fool

These Analysts Increase Their Forecasts On Medtronic After Strong Q2 Earnings

Medtronic Plc (NYSE: MDT) on Tuesday reported strong second-quarter 2026 results.

26 days ago - Benzinga

S&P 500 Gains and Losses Today: Home Depot Slumps as Earnings Disappoint; Medtronic Stock Jumps

Shares of a major home improvement retailer lost ground after it missed quarterly profit forecasts, indicating homeowners are putting off remodeling projects amid economic uncertainty. Meanwhile, stro...

Other symbols: HD
27 days ago - Investopedia

Why biotech and drug stocks are on the mend even though the rest of the market is hurting

Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded away.

Other symbols: AZNJNJLLYMRKNVOOLMAPFE
27 days ago - Market Watch

Medtronic plc (MDT) Q2 2026 Earnings Call Transcript

Medtronic plc ( MDT) Q2 2026 Earnings Call November 18, 2025 8:00 AM EST Company Participants Ryan Weispfenning - VP & Head of Investor Relations Geoffrey Martha - Chairman of the Board & CEO Thierry...

27 days ago - Seeking Alpha

Medtronic Lifts Outlook as Quarterly Profit, Sales Rise

Medtronic raised its fiscal-year outlook after logging higher profit and sales in its latest quarter, boosted by robust demand across end markets and healthy procedure volumes.

4 weeks ago - WSJ

Medtronic Stock Rises After Earnings. What Caught Investors' Attention.

Medtronic exceeds fiscal second-quarter earnings and revenue expectations.

4 weeks ago - Barrons

Medtronic beats second-quarter estimates on strength in heart devices segment

Medical device maker Medtronic topped Wall Street estimates for second-quarter profit and revenue on Tuesday, driven by strong demand for its heart disease and diabetes devices.

4 weeks ago - Reuters

Medtronic reports strong second quarter fiscal 2026 financial results, enterprise growth drivers accelerate momentum

Cardiac Ablation Solutions growth of 71% on strength of pulsed field ablation (PFA) portfolio; Raising FY26 revenue and EPS guidance GALWAY, Ireland , Nov. 18, 2025 /PRNewswire/ -- Medtronic plc (NYSE...

4 weeks ago - PRNewsWire

Top Wall Street Forecasters Revamp Medtronic Expectations Ahead Of Q2 Earnings

Medtronic plc (NYSE: MDT) will release earnings results for the second quarter, before the opening bell on Tuesday, Nov. 18.

4 weeks ago - Benzinga